430 related articles for article (PubMed ID: 17304084)
21. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.
Jia YX; Cui FQ; Li L; Zhang DL; Zhang GM; Wang FZ; Gong XH; Zheng H; Wu ZH; Miao N; Sun XJ; Zhang L; Lv JJ; Yang F
Qual Life Res; 2014 Oct; 23(8):2355-63. PubMed ID: 24627090
[TBL] [Abstract][Full Text] [Related]
22. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.
Janssen MF; Pickard AS; Golicki D; Gudex C; Niewada M; Scalone L; Swinburn P; Busschbach J
Qual Life Res; 2013 Sep; 22(7):1717-27. PubMed ID: 23184421
[TBL] [Abstract][Full Text] [Related]
23. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
[TBL] [Abstract][Full Text] [Related]
24. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
25. Psychometric properties of the EQ-5D-5L in the general population of South Korea.
Kim TH; Jo MW; Lee SI; Kim SH; Chung SM
Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560
[TBL] [Abstract][Full Text] [Related]
26. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
[TBL] [Abstract][Full Text] [Related]
27. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
[TBL] [Abstract][Full Text] [Related]
28. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
Fitriana TS; Purba FD; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
[TBL] [Abstract][Full Text] [Related]
29. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.
Yfantopoulos JN; Chantzaras AE
Eur J Health Econ; 2017 May; 18(4):519-531. PubMed ID: 27262480
[TBL] [Abstract][Full Text] [Related]
30. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
[TBL] [Abstract][Full Text] [Related]
31. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the three-level and the five-level versions of the EQ-5D.
Christiansen ASJ; Møller MLS; Kronborg C; Haugan KJ; Køber L; Højberg S; Brandes A; Graff C; Diederichsen SZ; Nielsen JB; Krieger D; Holst AG; Svendsen JH
Eur J Health Econ; 2021 Jun; 22(4):621-628. PubMed ID: 33733344
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in patients with lower limb amputation - an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.
Ernstsson O; Hagberg K; Janssen MF; Bonsel GJ; Korkmaz S; Zethraeus N; Heintz E
Disabil Rehabil; 2022 Dec; 44(26):8471-8479. PubMed ID: 34932426
[TBL] [Abstract][Full Text] [Related]
35. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
[TBL] [Abstract][Full Text] [Related]
36. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
37. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
[TBL] [Abstract][Full Text] [Related]
38. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
39. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
[TBL] [Abstract][Full Text] [Related]
40. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]